NTCB02-1 trial for patients needing IV nutrition
Part of Digestive system clinical trials.
This trial tests an investigational IV nutrition product called NTCB02-1 in patients who need nutrition through a vein (parenteral nutrition) for at least 3 days. It aims to see if it is safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You need nutrition through a vein for more than 3 days.
- You are expected to survive at least 3 days.
- You are not allergic to peanuts, fish, soy, eggs, or the study drug.
- You can have a central vein line placed safely.
- Your body mass index (BMI) is 30 or lower.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special approach to nutrition for patients on breathing machines who have trouble digesting food. It aims to see if the new method helps meet nutritional needs better.
This trial compares two ways of feeding patients after they recover from shock in the ICU: through a feeding tube (enteral nutrition) or through a vein (parenteral nutrition). It aims to see which method helps patients recover better.
This trial tests whether giving IV nutrition (supplemental parenteral nutrition) at different times helps critically ill patients who are not getting enough calories from tube feeding alone. It may improve recovery for people with organ failure in the ICU.
This trial tests a new medicine called PJ009 for people with short bowel syndrome who need intravenous (IV) nutrition support. It aims to help reduce the need for IV nutrition. To join, you must have been dependent on IV nutrition for at least six months and be on a stable schedule.
This trial looks at how nutrition is given to children in the pediatric intensive care unit (PICU), especially for those who stay longer than 3 days. The goal is to find better ways to support their recovery.
This early-phase trial tests the safety of a new drug called NTB003 in healthy people. It looks at how the drug moves through the body and affects it, which is a first step toward possibly treating certain conditions.
Hear when a new Parenteral Nutrition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.